Birdwatch Archive

Birdwatch Note Rating

2024-11-29 04:04:48 UTC - NOT_HELPFUL

Rated by Participant: A5FCED87EC8F2599BFAC54E321C65B1BDC4779E961125ED82B81238BC0A73B92
Participant Details

Original Note:

The new rule proposal does not mandate Ozempic as an obesity treatment. The proposed rule changes a decades-old Medicare rule that prohibits the program from covering weight loss drugs. This makes Ozempic and other semaglutides available to those covered by Medicare. https://apnews.com/article/ozempic-biden-rfk-jr-trump-antiobesity-drugs-caaa2f888435af1d32bedb83e9ddbc0a

All Note Details

Original Tweet

All Information

  • noteId - 1862229962469658685
  • participantId -
  • raterParticipantId - A5FCED87EC8F2599BFAC54E321C65B1BDC4779E961125ED82B81238BC0A73B92
  • createdAtMillis - 1732853088530
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - NOT_HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 0
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 0
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 0
  • helpfulImportantContext - 0
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 1
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 1
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 1
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 1
  • notHelpfulNoteNotNeeded - 1
  • ratingsId - 1862229962469658685A5FCED87EC8F2599BFAC54E321C65B1BDC4779E961125ED82B81238BC0A73B92